MIST

MILESTONE PHARMACEUTICALS IN

MIST·59935V107·US·Common Stock·Healthcare - Biotechnology-13D/G

MIST (MILESTONE PHARMACEUTICALS IN) is held by 45 institutional investors as of Q1 2026. Largest holders: RTW INVESTMENTS, LP ($7.5M), TWO SIGMA INVESTMENTS, LP ($2.8M), GOLDMAN SACHS GROUP INC ($2.4M). Net institutional sentiment: Mixed.

45
Holders
Avg rating(12 Elite)
$25M
Total Value
58% (52)
Fund Consensus
26 buying - 19 selling
MISTSmart Money Verdict
View all
Held by 45 funds
12 elite
Who's Trading
ActivistRTW Investments, LPRTW Investments, LP9.9%May 15, 2026
ActivistADAdage Capital Management, L.P.6.4%May 13, 2026
InsiderOJOliveto JosephSell $82KApr 16, 2026
ActivistTETrails Edge Capital Partners, LP4.3%Mar 26, 2026
InsiderOJOliveto JosephSell $67KJan 26, 2026
InsiderMLMuller LorenzSell $22KJan 26, 2026
InsiderBDBharucha DavidSell $24KJan 26, 2026
InsiderHAHasija AmitSell $24KJan 26, 2026
InsiderNENelson Jeffrey EdwardSell $24KJan 26, 2026
ActivistPBPropel Bio Management, LLC9.9%Dec 23, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
6.3M(+152.6%)$7.5M0.1%-87.75%
44
Increased
2.3M(+53.0%)$2.8M0.0%-31.65%
37
New
2M$2.4M0.0%-22.42%
36
Increased
1.9M(+17.4%)$2.3M0.0%-33.66%
30
Increased
1.5M(+283.6%)$1.8M0.0%-26.82%
42
Increased
1.1M(+125.1%)$1.3M0.0%-28.40%
41
New
851,325$1M0.0%-22.42%
35
Unchanged
750,000$892,5000.0%-43.11%
0
Decreased
724,141(-7.4%)$861,7270.0%-33.05%
0
Decreased
519,046(-19.3%)$617,6650.0%-34.26%
0
Increased
494,908(+0.6%)$588,9400.0%-33.69%
24
Increased
336,825(+35.1%)$400,8220.0%-31.90%
31
Increased
280,250(+6.5%)$333,4980.0%-35.79%
25
Decreased
196,696(-44.3%)$234,0680.0%-36.95%
0
Increased
193,373(+35.7%)$230,1140.0%-30.71%
30
Decreased
176,504(-20.5%)$210,0400.0%-34.69%
0
Decreased
159,669(-85.4%)$190,0060.0%-35.39%
0
New
149,291$177,6560.0%-22.42%
31
New
149,105$177,4350.0%-22.42%
31
Decreased
129,764(-33.5%)$154,4190.0%-34.02%
0

Showing 1-20 of 52

1 / 3

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used